Although best-practice standards for clinical guidelines have been released by the Institute of Medicine and Guidelines International Network, a great challenge remains for guideline development for patients afflicted with rare diseases. This article reviews the challenge of guideline development under these circumstances with an emphasis on strategies to overcome these challenges. Guideline development and use in practice have become integral components in the contemporary care of patients to optimize outcome results. The guidelines are developed through an objective, evidence-based process conducted by experts and stakeholders for a given disease process.
PaiMIorioAMeerpohlJet al. Developing methodology for the creation of clinical practice guidelines for rare diseases: a report from RARE-Bestpractices. Rare Diseases. 2015;3(1):e1058463.
2.
LilfordRJThorntonJGBraunholtzD. Clinical trials and rare diseases: a way out of a conundrum. BMJ. 1995;311:1621-1625.
3.
LuisettiMCampoIScabiniRet al. The problems of clinical trials and registries in rare diseases. Respir Med. 2010;104(suppl 1):S42-S44.
4.
AndrewsJCSchunemannHJOxmanADet al. GRADE guidelines: 15. Going from evidence to recommendation: determinants of a recommendation’s direction and strength. J Clin Epidemiol. 2013;66:726-735.
5.
AndrewsJGuyattGOxmanADet al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719-725.
6.
BrozekJLAklEACompalatiEet al. Grading quality of evidence and strength of recommendation in clinical practice guidelines: part 3 of 3. The GRADE approach to developing recommendations. Allergy. 2011;66:588-595.
7.
LevinAWheelerDC. A fine balance: developing clinical practice guidelines in areas where evidence is lacking. Semin Dial. 2015;28(6):654-656.
8.
KrempODosquetPRathA. Professional clinical guidelines for rare diseases: methodology. Orphanet J Rare Dis. 2012;7(suppl 2):A12.
9.
CuiYZhouXHanJ. China launched a pilot project to improve its rare disease healthcare levels. Orphanet J Rare Dis. 2014;9:14.
10.
Gideon-LewisK. Going neural. New York Times Magazine. December18, 2016:40-49.
